CHPA has signed onto a letter from the California Chamber of Commerce opposing OEHHA’s proposed amendments to the Article 6 Short-Form Warning Requirements under Prop 65.
CHPA released the following statement in response to new research published in Clinical Toxicology. The study found nine illegal stimulants, including deterenol, in fraudulently marketed sports and weight loss supplements.
On Wednesday, March 17, Mississippi Governor Tate Reeves signed S.B. 2119, repealing a law that overturns the state’s ban of over-the-counter (OTC) sales of pseudoephedrine (PSE).
This week, the House Judiciary Committee had scheduled a hearing on the SHOP SAFE Act, entitled, "The SHOP SAFE Act: Stemming the Rising Tide of Unsafe Counterfeit Products Online." CHPA is an enthusiastic supporter of the SHOP SAFE Act.
In a major victory for consumer health, today Mississippi has repealed an 11-year-old law that banned over-the-counter (OTC) sales of certain medicines for colds and allergies containing the decongestant pseudoephedrine (PSE).
On Tuesday, March 9, the Mississippi House voted to repeal the state’s existing ban of over-the-counter (OTC) sales of pseudoephedrine (PSE) on an 117-3 vote. Since 2010, Mississippi has categorized PSE as a schedule III controlled substance.
